Trial Profile
Relative Bioavailability of Crushed Apixaban Tablets Administered With Water or Apple Sauce Compared With Intact Tablet in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 09 Jun 2016 Results of pooled analysis of two phase I studies published in the Clinical Therapeutics
- 10 Jun 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2014 New trial record